Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
33.92
+0.34 (1.01%)
At close: May 12, 2026, 4:00 PM EDT
33.73
-0.19 (-0.56%)
After-hours: May 12, 2026, 8:00 PM EDT
HELX Holdings Information
HELX is an equity ETF with a total of 66 individual holdings. The top holdings are Guardant Health stock at 6.88%, Natera at 6.34%, Krystal Biotech at 6.18%, United Therapeutics at 4.34%, and Ligand Pharmaceuticals at 3.84%.
Total Holdings
66
Top 10 Percentage
43.30%
Asset Class
Equity
ETF Category
Health
Assets
21.81M
PE Ratio
29.38
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GH | Guardant Health, Inc. | 6.88% |
| 2 | NTRA | Natera, Inc. | 6.34% |
| 3 | KRYS | Krystal Biotech, Inc. | 6.18% |
| 4 | UTHR | United Therapeutics Corporation | 4.34% |
| 5 | LGND | Ligand Pharmaceuticals Incorporated | 3.84% |
| 6 | BBIO | BridgeBio Pharma, Inc. | 3.76% |
| 7 | LON: AZN | AstraZeneca PLC | 3.09% |
| 8 | ADPT | Adaptive Biotechnologies Corporation | 3.05% |
| 9 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 2.99% |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | 2.82% |
| 11 | INSM | Insmed Incorporated | 2.75% |
| 12 | LLY | Eli Lilly and Company | 2.57% |
| 13 | CTVA | Corteva, Inc. | 2.56% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 2.45% |
| 15 | n/a | Cash | 2.33% |
| 16 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.28% |
| 17 | TVTX | Travere Therapeutics, Inc. | 2.10% |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 2.06% |
| 19 | MEDP | Medpace Holdings, Inc. | 2.04% |
| 20 | TEM | Tempus AI, Inc. | 1.99% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.88% |
| 22 | BNTX | BioNTech SE | 1.87% |
| 23 | TWST | Twist Bioscience Corporation | 1.87% |
| 24 | EBR: ARGX | argenx SE | 1.66% |
| 25 | STOK | Stoke Therapeutics, Inc. | 1.59% |
As of May 8, 2026